Financial & competing interests disclosure
Georg Maschmeyer has served as a consultant for Gilead Sciences, Merck/MSD, Pfizer and Essex/Schering-Plough and has been on the Speakers’ Bureau for Gilead Sciences, Merck/MSD, Pfizer and Cephalon. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.